New York City Washington D.C.
OUR INSPIRATION
The U.S. currently spends nearly four trillion dollars on healthcare which is 19% of the GDP.
Despite this incredible investment, access barriers to life saving medical innovations are alarming and have created a unique public health challenge. While the correlation between the price and overall value of medical innovations will continue to be debated, one thing will not, patients require timely affordable treatment with the most advanced and effective therapies. As a society, we must find a solution to maintain the ecosystem of continuous medical innovation and ensure access for patients.
OUR EXPERTS
We are the leading global group of senior executives from Pharmaceutical, Biotechnology, Medical Device Industry, Private and Public Payers, Academia, Providers, Hospital Administration, Investment Community, and Policy Research Institutes to address sustainable medical innovation, rapid and affordable patient access, informed policy making and talent development in market access and health policy.
OUR SOLUTIONS
Patient Centric Market Access & Pricing Strategy
Investment Strategy for Financial Community & Medical Technology Industry
Patient Centric Evidence generation Strategy
Organizational Design to Accommodate Changed Market Place
Informed Policy Making
Talent Development
Stakeholder Collaboration